News tagged with respiratory infection

Related topics: children

Venclexta approved for specific genetic blood cancer

(HealthDay)—Venclexta (venetoclax) has been approved by the U.S. Food and Drug Administration to treat chronic lymphocytic leukemia (CLL) characterized by a specific chromosomal abnormality called the 17p deletion.

Apr 11, 2016
popularity0 comments 0

Subscribe to rss feed